JP4023828B2 - 人工腎臓および腎臓疾患治療へのその利用 - Google Patents

人工腎臓および腎臓疾患治療へのその利用 Download PDF

Info

Publication number
JP4023828B2
JP4023828B2 JP51283398A JP51283398A JP4023828B2 JP 4023828 B2 JP4023828 B2 JP 4023828B2 JP 51283398 A JP51283398 A JP 51283398A JP 51283398 A JP51283398 A JP 51283398A JP 4023828 B2 JP4023828 B2 JP 4023828B2
Authority
JP
Japan
Prior art keywords
kidney
cells
membrane structure
porous membrane
analog
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP51283398A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001506871A (ja
JP2001506871A5 (enExample
Inventor
アタラ，アンソニー
ヨー，ジェームズ・ジェイ
アシュカー，サミー
Original Assignee
チルドレンズ・メディカル・センター・コーポレーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by チルドレンズ・メディカル・センター・コーポレーション filed Critical チルドレンズ・メディカル・センター・コーポレーション
Publication of JP2001506871A publication Critical patent/JP2001506871A/ja
Publication of JP2001506871A5 publication Critical patent/JP2001506871A5/ja
Application granted granted Critical
Publication of JP4023828B2 publication Critical patent/JP4023828B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/26—Materials or treatment for tissue regeneration for kidney reconstruction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • External Artificial Organs (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Prostheses (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP51283398A 1996-09-05 1997-09-04 人工腎臓および腎臓疾患治療へのその利用 Expired - Fee Related JP4023828B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2551196P 1996-09-05 1996-09-05
US60/025,511 1996-09-05
PCT/US1997/015470 WO1998009582A1 (en) 1996-09-05 1997-09-04 Prosthetic kidney and its use for treating kidney disease

Publications (3)

Publication Number Publication Date
JP2001506871A JP2001506871A (ja) 2001-05-29
JP2001506871A5 JP2001506871A5 (enExample) 2005-05-12
JP4023828B2 true JP4023828B2 (ja) 2007-12-19

Family

ID=21826516

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51283398A Expired - Fee Related JP4023828B2 (ja) 1996-09-05 1997-09-04 人工腎臓および腎臓疾患治療へのその利用

Country Status (6)

Country Link
EP (1) EP0929271B1 (enExample)
JP (1) JP4023828B2 (enExample)
AT (1) ATE260076T1 (enExample)
AU (1) AU4331897A (enExample)
DE (1) DE69727817T2 (enExample)
WO (1) WO1998009582A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5166275B2 (ja) * 2006-10-17 2013-03-21 学校法人東海大学 バイオ人工尿細管

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1032435B1 (en) 1997-10-31 2003-09-03 Children's Medical Center Corporation Bladder reconstruction
US6479064B1 (en) 1999-12-29 2002-11-12 Children's Medical Center Corporation Culturing different cell populations on a decellularized natural biostructure for organ reconstruction
US6428802B1 (en) 1999-12-29 2002-08-06 Children's Medical Center Corp. Preparing artificial organs by forming polylayers of different cell populations on a substrate
US6368859B1 (en) 1999-12-29 2002-04-09 Children's Medical Center Corporation Methods and compositions for producing a fascial sling
AT411328B (de) * 2000-07-12 2003-12-29 Universitaetsklinikum Freiburg Röhrensystem zur rekonstruktion einer harnröhre
KR100864648B1 (ko) * 2001-05-17 2008-10-23 가부시키가이샤 가네카 단백질 대사 기능을 갖는 인공 신장 및 그 제작 방법
JP4358621B2 (ja) * 2001-08-08 2009-11-04 泰彦 田畑 細胞と細胞増殖因子とからなる腎臓の再生のための材料
AU2007201136B2 (en) * 2001-11-16 2011-03-03 Children's Medical Center Corporation Augmentation of organ function
EP2292278B1 (en) * 2001-11-16 2013-04-24 Children's Medical Center Corporation Augmentation of organ function
ATE439039T1 (de) 2003-01-16 2009-08-15 Gen Hospital Corp Verwendung von dreidimensionalen, mikrogefertigten, mittels gewebetechnologie hergestellten systemen für pharmakologische anwendungen
US8353896B2 (en) 2004-04-19 2013-01-15 The Invention Science Fund I, Llc Controllable release nasal system
US7857767B2 (en) 2004-04-19 2010-12-28 Invention Science Fund I, Llc Lumen-traveling device
US9011329B2 (en) 2004-04-19 2015-04-21 Searete Llc Lumenally-active device
US8512219B2 (en) 2004-04-19 2013-08-20 The Invention Science Fund I, Llc Bioelectromagnetic interface system
US8092549B2 (en) * 2004-09-24 2012-01-10 The Invention Science Fund I, Llc Ciliated stent-like-system
US8337482B2 (en) 2004-04-19 2012-12-25 The Invention Science Fund I, Llc System for perfusion management
US8024036B2 (en) 2007-03-19 2011-09-20 The Invention Science Fund I, Llc Lumen-traveling biological interface device and method of use
US7998060B2 (en) 2004-04-19 2011-08-16 The Invention Science Fund I, Llc Lumen-traveling delivery device
US8361013B2 (en) 2004-04-19 2013-01-29 The Invention Science Fund I, Llc Telescoping perfusion management system
US20120035438A1 (en) 2006-04-12 2012-02-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Path selection by a lumen traveling device in a body tub tree based on previous path
JP2010528658A (ja) * 2007-06-08 2010-08-26 ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ 腎不全の治療のための選択的細胞治療
KR102428795B1 (ko) * 2008-11-12 2022-08-04 인리젠 분리된 신장 세포 및 이의 용도
WO2010057015A1 (en) 2008-11-14 2010-05-20 Wake Forest University Health Sciences Kidney structures and methods of forming the same
WO2010057013A1 (en) 2008-11-14 2010-05-20 Wake Forest University Health Sciences Selective cell therapy for the treatment of renal failure
KR101227453B1 (ko) * 2010-07-29 2013-01-29 서강대학교산학협력단 인공 신단위 장치
CN107002033B (zh) * 2014-10-06 2021-08-10 奥加诺沃公司 工程化肾组织、其阵列及其制备方法
CN107921178A (zh) * 2015-05-05 2018-04-17 哈佛大学的校长及成员们 管状组织构造和打印方法
JP2019521769A (ja) 2016-07-14 2019-08-08 キドニ ラボズ, インク.Qidni Labs, Inc. 生体適合性且つ血液適合性の材料及びフィルタ
AU2017335841A1 (en) 2016-09-28 2019-04-04 Organovo, Inc. Use of engineered renal tissues in assays
US11844891B2 (en) * 2017-05-14 2023-12-19 Paragate Medical Ltd. Implantable fluid extraction system
US10822461B2 (en) 2017-10-05 2020-11-03 Fresenius Medical Care Holdings, Inc. Polysulfone-urethane copolymer, membranes and products incorporating same, and methods for making and using same
KR102795670B1 (ko) * 2019-03-06 2025-04-15 감브로 룬디아 아베 알칼리성 포스파타제를 포함하는 혈액 처리 장치
CN120168756A (zh) * 2025-03-10 2025-06-20 中国人民解放军总医院第一医学中心 一种智能化的生物肾透析治疗装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266480A (en) * 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US4769037A (en) * 1986-10-28 1988-09-06 Midcalf Robert J Artificial replacement kidney implant and method of dialyzing blood
AU2900792A (en) * 1991-10-24 1993-05-21 Children's Medical Center Corporation Neomorphogenesis of urological structures in vivo from cell culture
US5429938A (en) * 1992-03-02 1995-07-04 University Of Michigan Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules
US5549674A (en) * 1992-03-02 1996-08-27 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5166275B2 (ja) * 2006-10-17 2013-03-21 学校法人東海大学 バイオ人工尿細管

Also Published As

Publication number Publication date
EP0929271B1 (en) 2004-02-25
WO1998009582A1 (en) 1998-03-12
EP0929271A1 (en) 1999-07-21
DE69727817T2 (de) 2005-01-05
DE69727817D1 (de) 2004-04-01
ATE260076T1 (de) 2004-03-15
AU4331897A (en) 1998-03-26
JP2001506871A (ja) 2001-05-29

Similar Documents

Publication Publication Date Title
EP0929271B1 (en) Prosthetic kidney
US6673339B1 (en) Prosthetic kidney and its use for treating kidney disease
US20040167634A1 (en) Prosthetic kidney and its use for treating kidney disease
Devalliere et al. Improving functional re-endothelialization of acellular liver scaffold using REDV cell-binding domain
JP3692147B2 (ja) フィルターデバイス
US5981211A (en) Maintaining cells for an extended time by entrapment in a contracted matrix
Cieslinski et al. Tissue engineering of a bioartificial kidney
JP2022107023A (ja) 臓器および組織を脱細胞化および再細胞化する方法
AU770887B2 (en) Reconstructing organs from decellularized biomaterial scaffold
Saxena et al. Vascularized three‐dimensional skeletal muscle tissue‐engineering
JP2022068312A (ja) 組織を培養する装置及び方法
JP2003527170A (ja) 多層組織構造の再構築方法および組成物
CA2121040A1 (en) Prevascularized polymeric implants for organ transplantation
CN102271722A (zh) 细胞支架构建体
JP2003521289A (ja) 流体に生物学的な変更を加えるための装置および方法
CN102861359A (zh) 器官和组织的脱细胞化和再细胞化
JPWO2005087286A1 (ja) 生体組織シート及びその作製方法、並びに同シートを用いる移植方法
JPH09512462A (ja) Ｉｎ ｖｉｔｒｏで合成された細胞外基質を利用した改善された血液接触表面
EP3498313A1 (en) Tubular protheses
CN104379726A (zh) 生物人工过滤器官
JP2005000608A (ja) 高生着性培養細胞シート、製造方法及びその利用方法
US7874998B2 (en) Filtration devices and related methods thereof
JPWO2005089823A1 (ja) 再生管腔臓器着生剤、着生可能型再生管腔臓器、着生可能型再生管腔臓器の製造方法、及び管腔臓器の再生着生方法
CN116942914B (zh) 人同种异体脱细胞基质组织工程心脏瓣膜、制备方法及应用
Nagashima et al. Basic studies on the application of an artificial esophagus using cultured epidermal cells

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040906

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040906

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060905

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20061204

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20070129

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070110

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070327

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20070329

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20070521

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070502

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20070904

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20071002

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101012

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111012

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121012

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131012

Year of fee payment: 6

LAPS Cancellation because of no payment of annual fees